0001628280-24-032155.txt : 20240717
0001628280-24-032155.hdr.sgml : 20240717
20240717213243
ACCESSION NUMBER: 0001628280-24-032155
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240715
FILED AS OF DATE: 20240717
DATE AS OF CHANGE: 20240717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HOPKINS SHEILA
CENTRAL INDEX KEY: 0001248574
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50644
FILM NUMBER: 241123573
MAIL ADDRESS:
STREET 1: C/O WARNACO INC
STREET 2: 90 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUTERA INC
CENTRAL INDEX KEY: 0001162461
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 770492262
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3240 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 94005
MAIL ADDRESS:
STREET 1: 3240 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: ALTUS MEDICAL INC
DATE OF NAME CHANGE: 20011119
4
1
wk-form4_1721266356.xml
FORM 4
X0508
4
2024-07-15
0
0001162461
CUTERA INC
CUTR
0001248574
HOPKINS SHEILA
C/O CUTERA, INC.
3240 BAYSHORE BLVD.
BRISBANE
CA
94005
1
0
0
0
0
Stock Option (Right to Buy)
36.55
2024-07-15
4
D
0
3627
0
D
2023-07-13
2029-06-16
COMMON STOCK
3627
0
D
Stock Option (Right to Buy)
1.54
2024-07-15
4
A
0
3627
0
A
2023-07-13
2029-06-16
COMMON STOCK
3627
3627
D
Stock Option (Right to Buy)
15.83
2024-07-15
4
D
0
7770
0
D
2024-07-15
2030-07-14
COMMON STOCK
7770
0
D
Stock Option (Right to Buy)
1.54
2024-07-15
4
A
0
7770
0
A
2024-07-15
2030-07-14
COMMON STOCK
7770
7770
D
On July 15, 2024, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $1.54 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
/s/ Sheila Hopkins
2024-07-17